Xicogab (Pregabalin): Clinically Established Neuromodulatory Efficacy for Low Back Pain, Fibromyalgia, and Chronic Neuropathic Discomfort
Breaking free from debilitating nerve-related discomfort and restoring deep, refreshing sleep requires a targeted pharmacological approach that addresses nerve excitability at its core. Xicogab features premium Pregabalin, a robust therapeutic molecule highly recognized for its ability to stabilize overactive neural pathways. By calming excessive neurotransmitter release, Xicogab successfully dampens hyper-sensitized pain signaling throughout the central nervous system, delivering reliable comfort and profound functional recovery where traditional over-the-counter painkillers often fall short.
Clinical data highlighted in XICOGAB_2.jpeg emphasizes that neuropathic pain is a major contributor to more than 50% of the patient population suffering from low back pain. Because chronic back issues are frequently mixed with complex nerve irritation, standalone anti-inflammatory treatments can provide incomplete relief. Incorporating a Xicogab addition to standard NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) is statistically proven to be significantly more effective than utilizing standard monotherapy for low back pain management, offering clinicians and patients a superior path toward complete physical rehabilitation.
-
Reduces Awake Disruptions: It actively cuts down nighttime restlessness, reducing wakefulness after sleep onset by 19.2 minutes ($p<0.0001$).
-
Increases Deep Sleep Duration: It optimizes total nocturnal rest, increasing total sleep time by an average of 25 minutes ($p<0.0001$).
-
Lowers Objective Pain Scores: By delivering systemic neural stabilization, Pregabalin yields a significantly lower overall pain score when evaluated against a placebo control ($P=0.008$).






Reviews
There are no reviews yet.